Showing results (181-190 of 252) with videos related to

Sort By:
Pageof 26
Chest|September 21, 2013
Sirolimus decreases circulating lymphangioleiomyomatosis cells in patients with lymphangioleiomyomatosisXiong Cai, Gustavo Pacheco-Rodriguez, Mary Haughey, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|March 10, 2019
Kadsura heteroclita stem suppresses the onset and progression of adjuvant-induced arthritis in ratsHuanghe Yu, Rong Zeng, Ye Lin, et al.
Targeted Oncology|October 19, 2023
Dual PI3K/HDAC Inhibitor BEBT-908 Exhibits Potent Efficacy as Monotherapy for Primary Central Nervous System LymphomaNing Wang, Zhenxian Mo, Lu Pan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 13, 2026
Glypican-3-targeted immunoPET imaging of hepatocellular carcinoma: a translational studyZhaoguo Lin, Wenzhu Hu, Mengting Li, et al.
International Journal of Cancer|May 26, 2017
Circulating tumor DNA profiling reveals clonal evolution and real-time disease progression in advanced hepatocellular carcinomaZhi-Xiong Cai, Geng Chen, Yong-Yi Zeng, et al.
Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University|June 24, 2006
[Correlation between pressure-derived coronary collateral flow and Rentrop grade after primary percutaneous intervention of acute myocardial infarction]Zhi-xiong Cai, Xiao-qing Wang, Bin Lan, et al.
Autism Research : Official Journal of the International Society for Autism Research|March 8, 2017
Aggressive behaviors and treatable risk factors of preschool children with autism spectrum disorderChen Chen, Yi-Dong Shen, Guang-Lei Xun, et al.
The Oncologist|June 20, 2023
Safety, Tolerability, and Pharmacokinetics of Senaparib, a Novel PARP1/2 Inhibitor, in Chinese Patients With Advanced Solid Tumors: A Phase I TrialJunning Cao, Hongqian Guo, Dongmei Ji, et al.
Translational Oncology|December 15, 2020
BEBT-109, a pan-mutant-selective EGFR inhibitor with potent antitumor activity in EGFR-mutant non-small cell lung cancerFushun Fan, Minhua Zhou, Xiaolan Ye, et al.
British Journal of Pharmacology|September 13, 2003
MX1013, a dipeptide caspase inhibitor with potent in vivo antiapoptotic activityWu Yang, John Guastella, Jin-Cheng Huang, et al.
Pageof 26